Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Skin Neoplasms × Arsenic Trioxide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Promyelocytic, Acute 3 Multiple Myeloma 2 Leukemia, Myeloid, Acute 2 Leukemia 2 Wilms Tumor 1 Testicular Neoplasms 1 Teratoma 1 Skin Neoplasms 1 Sarcoma 1 Retinoblastoma 1 Recurrence 1 Ovarian Neoplasms 1 Ovarian Germ Cell Cancer 1 Osteosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Medulloblastoma 1 Lung Neoplasms 1 Liver Neoplasms 1 Kidney Neoplasms 1 Hepatoblastoma 1 Endometrial Neoplasms 1 Desmoplastic Small Round Cell Tumor 1 Childhood Acute Promyelocytic Leukemia With PML-RARA 1 Central Nervous System Neoplasms 1 Carcinoma, Small Cell 1 Carcinoma, Hepatocellular 1 Carcinoma, Basal Cell 1

Interventions

aldesleukin 14 Cyclophosphamide 14 fludarabine phosphate 11 fludarabine 11 Interleukin-2 9 Ipilimumab 6 Temozolomide 4 Nivolumab 4 trametinib 2 sonidegib 2 pembrolizumab 2 dabrafenib 2 binimetinib 2 Whole-Body Irradiation 2 Vemurafenib 2 Tacrolimus 2 Sodium Chloride 2 Sirolimus 2 Radiotherapy 2 Radiation 2 Peptides 2 Gefitinib 2 Fluorouracil 2 Dacarbazine 2 Cyclosporine 2 Capecitabine 2 veliparib 1 varlilumab 1 tilsotolimod 1 spartalizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01791894 2018-06-08

ATO

Stanford University

Phase 1/2 Completed

5 enrolled 9 charts

Carcinoma, Basal Cell, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡